{"authors": [["Berry-Kravis", "Elizabeth M", "EM", "Departments of Pediatrics, Neurological Sciences and Biochemistry, Rush University Medical Center, 1725 West Harrison Street, Suite 718, Chicago, Illinois 60612, USA."], ["Lindemann", "Lothar", "L", "Roche Pharmaceuticals Research and Early Development, Discovery Neuroscience, Neuroscience, Ophthalmology, and Rare Diseases, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland."], ["J\u00f8nch", "Aia E", "AE", "Department of Clinical Genetics, Odense University Hospital, Sdr. Boulevard 29, Odense C, Denmark."], ["Apostol", "George", "G", "Formerly at Neuroscience Development, Novartis Pharma AG, Fabrikstrasse 2, 4056 Basel, Switzerland."], ["Bear", "Mark F", "MF", "Picower Institute for Learning and Memory, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, Massachusetts 02139, USA."], ["Carpenter", "Randall L", "RL", "Picower Institute for Learning and Memory, Massachusetts Institute of Technology, 43 Vassar St, Cambridge, Massachusetts 02139, USA."], ["Crawley", "Jacqueline N", "JN", "MIND Institute, University of California Davis School of Medicine, 2825 50th Street, Sacramento, California 95817, USA."], ["Curie", "Aurore", "A", "National Reference Center for Rare Diseases with Intellectual Disability, H\u00f4pital Femme-M\u00e8re-Enfant, Hospices Civils de Lyon, Universit\u00e9 de Lyon, Institut des Sciences Cognitives, CNRS UMR 5304, Boulevard Pinel 67, 69675 Bron Cedex, France."], ["Des Portes", "Vincent", "V", "National Reference Center for Rare Diseases with Intellectual Disability, H\u00f4pital Femme-M\u00e8re-Enfant, Hospices Civils de Lyon, Universit\u00e9 de Lyon, Institut des Sciences Cognitives, CNRS UMR 5304, Boulevard Pinel 67, 69675 Bron Cedex, France."], ["Hossain", "Farah", "F", "Neuroscience Development, Novartis Pharmaceutical Corporation, 1 Health Plaza, East Hanover, New Jersey 07936, USA."], ["Gasparini", "Fabrizio", "F", "Novartis Institutes for Biomedical Research, Neuroscience Research, Postfach, 4002 Basel, Switzerland."], ["Gomez-Mancilla", "Baltazar", "B", "Novartis Institutes for Biomedical Research, Neuroscience Research, Postfach, 4002 Basel, Switzerland."], ["Hessl", "David", "D", "MIND Institute, University of California Davis School of Medicine, 2825 50th Street, Sacramento, California 95817, USA."], ["Loth", "Eva", "E", "Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK."], ["Scharf", "Sebastian H", "SH", "Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland."], ["Wang", "Paul P", "PP", "Simons Foundation, 160 Fifth Avenue, 7th Floor, New York, New York 10010, USA."], ["Von Raison", "Florian", "F", "Neuroscience Development, Novartis Pharma AG, Fabrikstrasse 2, 4056 Basel, Switzerland."], ["Hagerman", "Randi", "R", "MIND Institute, University of California Davis School of Medicine, 2825 50th Street, Sacramento, California 95817, USA."], ["Spooren", "Will", "W", "Roche Pharmaceuticals Research and Early Development, Discovery Neuroscience, Neuroscience, Ophthalmology, and Rare Diseases, Roche Innovation Center Basel, Grenzacherstrasse 124, 4070 Basel, Switzerland."], ["Jacquemont", "S\u00e9bastien", "S", "Service de G\u00e9n\u00e9tique M\u00e9dicale, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, 1011 Lausanne and University of Lausanne, Switzerland."]], "doi": "10.1038/nrd.2017.221", "date": "2018-01-16_23:19:14", "journal": ["Nature reviews. Drug discovery", "Nat Rev Drug Discov"], "year": null, "title": "Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.", "id": "29217836", "text": ["neurodevelopmental", "disorders", "fragile", "x", "syndrome", "fxs", "result", "lifelong", "cognitive", "behavioural", "deficits", "represent", "major", "public", "health", "burden", "fxs", "frequent", "monogenic", "form", "intellectual", "disability", "autism", "underlying", "pathophysiology", "linked", "causal", "gene", "fmr1", "focus", "intense", "research", "key", "alterations", "synaptic", "function", "thought", "underlie", "neurodevelopmental", "disorder", "characterized", "rescued", "animal", "models", "fxs", "using", "genetic", "pharmacological", "approaches", "robust", "preclinical", "findings", "led", "implementation", "comprehensive", "drug", "development", "programme", "undertaken", "thus", "far", "genetically", "defined", "neurodevelopmental", "disorder", "including", "phase", "iib", "trials", "metabotropic", "glutamate", "receptor", "5", "mglur5", "antagonists", "phase", "iii", "trial", "gabab", "receptor", "agonist", "however", "none", "trials", "able", "unambiguously", "demonstrate", "efficacy", "also", "highlighted", "extent", "knowledge", "gaps", "drug", "development", "fxs", "neurodevelopmental", "disorders", "review", "examine", "potential", "issues", "previous", "studies", "future", "directions", "preclinical", "clinical", "trials", "fxs", "forefront", "efforts", "develop", "drugs", "neurodevelopmental", "disorders", "lessons", "learned", "process", "also", "important", "disorders"]}